TFEB promotes Ginkgetin-induced ferroptosis via TRIM25 mediated GPX4 lysosomal degradation in EGFR wide-type lung adenocarcinoma

Haojie Wang, Lili Ding, Yuwen Zhang, Liping Zhao, Lihua Yu, Xiaoqi Tang, Ya-Xin Yan, Jian-Shu Lou

Theranostics · 2025 · 15 citations · 0 references

DOIFull text

Open access

Concepts

Abstract

: This study identifies, for the first time, GK as a promising TFEB agonist for LUAD treatment. TFEB activation promotes TRIM25-mediated K48-linked polyubiquitination and lysosomal degradation of GPX4, driving ferroptosis. This ferroptosis-driven mechanism offers a novel strategy to enhance ferroptosis-based anti-LUAD therapies.